This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fukuchi, M. Articles by Kuwano, H. Search for Related Content PubMed PubMed Citation Articles by Fukuchi, M. Articles by Kuwano, H.

High-Level Expression of the Smad Ubiquitin Ligase Smurf2 Correlates with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma¹

Department of Surgery I, Gunma University Faculty of Medicine, Maebashi 371-8511, Japan

Transforming growth factor ß (TGF-ß) regulates growth of various cells, and inactivation of the TGF-ß signaling pathway contributes to tumor progression. Smad2 is phosphorylated and activated by TGF-ß, resulting in the antiproliferative effects of TGF-ß signaling. Smurf2 (Smad ubiquitination regulatory factor 2) was identified as the Smad ubiquitin ligase that induces the ubiquitination and degradation of Smad2. This study was undertaken to elucidate the relationships between Smurf2 expression and the clinicopathological characteristics of patients with esophageal squamous cell carcinoma (SCC) and the correlation between Smurf2 and Smad2 expression. Surgical specimens obtained from 80 patients with esophageal SCC were subjected to immunohistochemical staining. Our data indicated that high-level expression of Smurf2 correlated with depth of invasion, lymph node metastasis, and a poor survival rate. We also found an inverse correlation between the expression of Smurf2 and Smad2. Western blotting analysis of esophageal SCC-derived cell lines revealed similar inverse correlations. We demonstrated that high-level expression of Smurf2 appears to correlate with tumor development and poor prognosis in patients with esophageal SCC and that alteration of Smad2 expression in the TGF-ß signaling pathway may be induced by enhancement of Smad2 degradation mediated by high-level expression of Smurf2.

This article has been cited by other articles:

				E. Glasgow and L. Mishra Transforming growth factor-{beta} signaling and ubiquitinators in cancer Endocr. Relat. Cancer, March 1, 2008; 15(1): 59 - 72. [Abstract] [Full Text] [PDF]

				Q. Yang, H.-Y. Lin, H.-X. Wang, H. Zhang, X. Zhang, H.-M. Wang, and C. Zhu Expression of Smad Ubiquitin Regulatory Factor 2 (Smurf2) in Rhesus Monkey Endometrium and Placenta During Early Pregnancy J. Histochem. Cytochem., May 1, 2007; 55(5): 453 - 460. [Abstract] [Full Text] [PDF]

				R. Tan, J. Zhang, X. Tan, X. Zhang, J. Yang, and Y. Liu Downregulation of SnoN Expression in Obstructive Nephropathy Is Mediated by an Enhanced Ubiquitin-Dependent Degradation J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2781 - 2791. [Abstract] [Full Text] [PDF]

				M. Liang, Y.-Y. Liang, K. Wrighton, D. Ungermannova, X.-P. Wang, F. C. Brunicardi, X. Liu, X.-H. Feng, and X. Lin Ubiquitination and Proteolysis of Cancer-Derived Smad4 Mutants by SCFSkp2 Mol. Cell. Biol., September 1, 2004; 24(17): 7524 - 7537. [Abstract] [Full Text] [PDF]